Science Explorer Back to mapMap
Discussion
Institution · Breast Center

Most cited papers from Breast Center

Breast Center

What are the most cited papers from Breast Center?

The most cited paper from Breast Center is "Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011" (Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al., 2011), with 3,932 citations. Next come "Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013" (3,776) and "Pembrolizumab for Early Triple-Negative Breast Cancer" (3,298).

Showing 50 of 60 papers. Every paper with more than 250 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al. · Annals of Oncology Open access 28 Jun 2011 3,932
2 Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch et al. · Annals of Oncology Open access 6 Aug 2013 3,776
3 Pembrolizumab for Early Triple-Negative Breast Cancer Peter Schmid et al. · New England Journal of Medicine Open access 26 Feb 2020 3,298
4 Breast cancer Nadia Harbeck, Frederique Madeleine Penault-Llorca, Javier Cortés et al. · Nature Reviews Disease Primers ReviewOpen access 23 Sep 2019 3,056
5 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) Fátima Cardoso et al. · Annals of Oncology Open access 11 Oct 2016 2,075
6 Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano, Karla V. Ballman, Linda Mackie McCall et al. · JAMA Open access 12 Sep 2017 1,941
7 Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan Stuart Coates et al. · Annals of Oncology Open access 4 May 2015 1,865
8 Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer Aditya Bardia et al. · New England Journal of Medicine Open access 21 Apr 2021 1,671
9 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) Fátima Cardoso et al. · Annals of Oncology Open access 23 Sep 2020 1,397
10 Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Aron Goldhirsch, James N. Ingle, Richard D. Gelber et al. · Annals of Oncology Open access 17 Jun 2009 1,381
11 Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Andreas Schneeweiß, Stephen Chia, Tamas Hickish et al. · Annals of Oncology Open access 23 May 2013 1,312
12 Neutrophils escort circulating tumour cells to enable cell cycle progression Barbara Maria Szczerba, Francesc Castro-Giner, Marcus Vetter et al. · Nature Open access 6 Feb 2019 1,274
13 De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano et al. · Annals of Oncology Open access 11 Jun 2017 1,263
14 Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation Noah D. Kauff, Jaya M. Satagopan, Mark E. Robson et al. · New England Journal of Medicine Open access 23 May 2002 1,257
15 Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Viviana Enrica Galimberti et al. · The Lancet Oncology Open access 10 Mar 2013 1,247
16 Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer Dennis J. Slamon et al. · New England Journal of Medicine Open access 11 Dec 2019 876
17 Shear-wave Elastography Improves the Specificity of Breast US: The BE1 Multinational Study of 939 Masses Wendie A. Berg, David Owen Cosgrove, Caroline J Doré et al. · Radiology 26 Jan 2012 844
18 Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding Sofia Gkountela, Francesc Castro-Giner, Barbara Maria Szczerba et al. · Cell Open access 2019 836
19 Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Olivia Pagani et al. · New England Journal of Medicine Open access Jun 2014 756
20 Percutaneous large-core breast biopsy: a multi-institutional study. S H Parker, Fred H. Burbank, R J Jackman et al. · Radiology Nov 1994 728
21 Prognostic classification of breast ductal carcinoma-in-situ David Nigel Poller, Alain Barth, Dennis J. Slamon et al. · The Lancet May 1995 680
22 The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast Melvin J. Silverstein, Michael D. Lagios, Susan G. Groshen et al. · New England Journal of Medicine Open access 13 May 1999 674
23 Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber et al. · Journal of Clinical Oncology Apr 1997 663
24 Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial Lee Gravatt Wilke, Linda Mackie McCall, Katherine E. Posther et al. · Annals of Surgical Oncology 2 Mar 2006 586
25 Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer Peter Schmid et al. · New England Journal of Medicine Open access 15 Sep 2024 544
26 Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function Suleiman Alfred Massarweh, Charles Kent Osborne, Chad J. Creighton et al. · Cancer Research Feb 2008 499
27 Dosage-Related Bifidogenic Effects of Galacto- and Fructooligosaccharides in Formula-Fed Term Infants Guido Eugenio Moro, IOLANDA MINOLI, Maurizio Mosca et al. · Journal of Pediatric Gastroenterology and Nutrition Mar 2002 494
28 Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase Maya Gutierrez, Simone I. DETRE, Stephen R.D. Johnston et al. · Journal of Clinical Oncology Open access 8 Mar 2005 491
29 MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis Atsushi Terunuma et al. · Journal of Clinical Investigation Open access 8 Dec 2013 472
30 Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up Meredith M. Regan, Patrick Neven, Anita Giobbie‐Hurder et al. · The Lancet Oncology Open access 24 Oct 2011 410
31 Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study Nadia Harbeck et al. · Annals of Oncology Open access 15 Oct 2021 390
32 Estimates of benefits and harms of prophylactic use of aspirin in the general population Jack M. Cuzick, Mangesh A. Thorat, Cristina Bosetti et al. · Annals of Oncology Open access 6 Aug 2014 390
33 Axillary lymph node dissection for t1a breast carcinoma. Is it indicated? Melvin J. Silverstein, Eugene D. Gierson, James R. Waisman et al. · Cancer Feb 1994 388
34 Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade Philipp Müller, Matthias Kreuzaler, Tarik A. Khan et al. · Science Translational Medicine 25 Nov 2015 345
35 Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy Ana Luísa Correia, Joao C. Guimaraes, Priska Auf der Maur et al. · Nature Open access 2 Jun 2021 343
36 The clinical significance of pre-invasive breast carcinoma Paul Peter Rosen, David W. Braun, David E. Kinne · Cancer Open access 15 Aug 1980 342
37 A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer Michele De Laurentiis, Grazia Arpino, Erminia Massarelli et al. · Clinical Cancer Research Review Jul 2005 342
38 CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial Meredith M. Regan, Brian R Leyland-Jones, Mark Bouzyk et al. · JNCI Journal of the National Cancer Institute Open access 6 Mar 2012 339
39 ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up Friedemann U. Honecker et al. · Annals of Oncology Open access 18 Jun 2018 331
40 Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review Élisabeth Luporsi et al. · Breast Cancer Research and Treatment Open access 2 Nov 2011 326
41 Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer Chang Gong, Yandan Yao, Ying Wang et al. · Journal of Biological Chemistry Open access 7 Apr 2011 312
42 Screening Breast Ultrasound: Past, Present, and Future Rachel F. Brem, Megan J. Lenihan, Jennifer H. Lieberman et al. · American Journal of Roentgenology Open access 23 Jan 2015 310
43 The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer Fátima Cardoso, Sibylle Loibl, Olivia Pagani et al. · European Journal of Cancer Open access 29 Oct 2012 310
44 Breast cancer in pregnancy: Recommendations of an international consensus meeting Frédéric Amant et al. · European Journal of Cancer 7 Oct 2010 308
45 Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial Toralf Reimer et al. · New England Journal of Medicine 12 Dec 2024 307
46 Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial Jayant Sharad Vaidya et al. · BMJ Open access 19 Aug 2020 297
47 Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study Syed K. Mohsin, Heidi L. Weiss, Thomas C. Havighurst et al. · Modern Pathology Open access 23 Jul 2004 292
48 Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials Gϋnter von Minckwitz et al. · Breast Cancer Research and Treatment Open access 2 Nov 2010 280
49 Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer Armando E. Giuliano, Debra Hawes, Karla V. Ballman et al. · JAMA Open access 26 Jul 2011 276
50 Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer William Chesnut Dooley et al. · JNCI Journal of the National Cancer Institute 7 Nov 2001 275

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.